Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Syncom Formulations (India) Ltd. Board/Management Information 2024

Aug 12, 2024

60987_rns_2024-08-12_15f25f75-d733-4df1-9ebf-7a2e7e432150.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [452 x 73] intentionally omitted <==

SYNCOM/SE/2024-25 12[th] August, 2024 Online filing at: www.listing.bseindia.com and https://neaps.nseindia.com/NEWLISTINGCORP/login.jsp

To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Tower, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai (M.H.) 400 001 Mumbai- 400051 BSE CODE:524470 NSE SYMBOL: SYNCOMF

Sub: Outcome of the 2/2024-25 Meeting of the Board of Directors of the Company held on Monday, 12[th] August 2024 at 207, Saket Nagar, Near Saket Club, Indore (M.P.) 452018 at 4:00 P.M. as per Regulation 30 read with Schedule III(A)(IV) of the SEBI(LODR) Regulations, 2015.

Dear Sir/Madam,

This has in reference to our letter No. SYNCOM/SE/2024-25 dated 2[nd] August, 2024 for notice under Regulation 29(1)(a) of SEBI (LODR) Regulations,2015 read with Regulation 30 of SEBI (LODR) Regulations,2015 and Schedule III of the said Regulations, by which it was informed that meeting No. 2/202425 of the Board of directors of the Company is to be held on Monday,12[th] August, 2024 at 4:00 P.M

We would like to inform that the Board of Directors of the Company at the aforesaid Board meeting have decided and approved the following business: -

  1. Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter ended 30[th] June, 2024.

  2. Taken on record the limited review report by the Auditors for the Standalone and Consolidated Financial results of the company for the Quarter ended 30[th] June, 2024.

  3. Finalization of the Annual Book Closure of the Company for the 36[th ] Annual General Meeting will be held on Monday the 30[th] day of September, 2024 at 2:00 P.M. through Video Conferencing / Other Audio-Visual Means (VC/OAVM).

  4. Finalization of the Cut-off Date for eligibility to participate in the Remote E-voting and E-voting at the 36[th] AGM.

  5. Appointment of Scrutinizer for the Remote E-voting as well as E-voting process at 36[th ] AGM.

  6. Re appointment of Shri Kedarmal Shankarlal Bankda, as the Chairman and Whole time Director, w.e.f., 2[nd] May, 2025 subject to the Confirmation by the member in the ensuing 36[th] Annual General Meeting.

  7. Re appointment of Shri Vijay Sharnkarlal Bankda, as the Managing Director of the Company w.e.f., 29[th] November, 2024 subject to the Confirmation by the member in the ensuing 36[th] Annual General Meeting.

  8. Other Routine business.

The information and disclosure are being filed pursuant to Regulation 29 read with Regulation 30 of the SEBI (LODR) Regulations, 2015.

The Board Meeting commenced at 4:00 P.M. and concluded at 4:30 P.M.

You are requested to please take on record our above said information for your reference and record and disseminate on the portal of the BSE and NSE for information to the investors and members of the Company. Thanking you,

Yours faithfully,

For, SYNCOM FORMULATIONS (INDIA) LIMITED

VAISHALI Digitally signed by VAISHALI AGRAWAL AGRAWAL Date: 2024.08.12 16:40:18 +05'30'

CS VAISHALI AGRAWAL COMPANY SECRETARY & COMPLIANCE OFFICER

==> picture [452 x 72] intentionally omitted <==